相似文献
1
Hormone replacement therapy and breast cancer: estimate of risk.
BMJ. 2005 Aug 6;331(7512):347-9. doi: 10.1136/bmj.331.7512.347.
2
Commentary on 'Hormone replacement therapy use and variations in the risk of breast cancer'.
BJOG. 2008 Jun;115(7):918. doi: 10.1111/j.1471-0528.2008.01733.x.
3
Oral contraceptives and the risk of breast cancer.
N Engl J Med. 2002 Oct 31;347(18):1448-9; author reply 1448-9.
4
[Hormone therapy and breast cancer].
Ugeskr Laeger. 2003 Sep 15;165(38):3631-2.
5
Decision about stopping hormone replacement therapy.
BMJ. 2010 Jul 7;341:c2421. doi: 10.1136/bmj.c2421.
6
[Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
Lakartidningen. 2009;106(34):2041-2.
7
The impact of hormone replacement therapy on the incidence of breast cancer in Norway.
J Clin Oncol. 2005 May 20;23(15):3636-7; author reply 3637-8. doi: 10.1200/JCO.2005.05.378.
8
Hormone replacement therapy. Public health concern is serious.
BMJ. 2002 Nov 23;325(7374):1243.
9
Hormone replacement therapy: the love affair is over (with response from Anna Fenton).
N Z Med J. 2002 Sep 13;115(1161):U162; discussion U162.
10
Hormone replacement therapy and the risk of breast cancer.
Eur J Cancer. 2008 Nov;44(16):2344-9. doi: 10.1016/j.ejca.2008.07.041. Epub 2008 Sep 8.
引用本文的文献
1
Mental and Physical Health Correlates of Tobacco Use Among Transgender Veterans of the Iraq and Afghanistan Conflicts.
Transgend Health. 2021 Oct 4;6(5):290-295. doi: 10.1089/trgh.2020.0051. eCollection 2021 Oct.
本文引用的文献
1
Changes in HT prescriptions in Australia since 1992.
Aust Fam Physician. 2005 Aug;34(8):697-8.
2
The Million Women Study: potential biases do not allow uncritical acceptance of the data.
Climacteric. 2004 Mar;7(1):3-7. doi: 10.1080/13697130310001651418.
3
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
JAMA. 2004 Apr 14;291(14):1701-12. doi: 10.1001/jama.291.14.1701.
4
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results.
Ann Intern Med. 2004 Feb 3;140(3):184-8. doi: 10.7326/0003-4819-140-3-200402030-00009.
5
The estimation of the probability of developing a disease in the presence of competing risks.
Am J Public Health Nations Health. 1957 May;47(5):601-7. doi: 10.2105/ajph.47.5.601.
6
Breast cancer and hormone-replacement therapy in the Million Women Study.
Lancet. 2003 Aug 9;362(9382):419-27. doi: 10.1016/s0140-6736(03)14065-2.
7
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.
JAMA. 2003 Jun 25;289(24):3243-53. doi: 10.1001/jama.289.24.3243.
8
Hormone replacement therapy use over a decade in an Australian population.
Climacteric. 2002 Dec;5(4):351-6.
9
Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Lancet. 2002 Sep 21;360(9337):942-4. doi: 10.1016/S0140-6736(02)11032-4.
10
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
Zotero 插件